-+ 0.00%
-+ 0.00%
-+ 0.00%

Tango Therapeutics President, R&D Crystal Adam disposes of USD 734,514 common shares

PUBT·08/05/2026 20:02:01
Listen to the news
Tango Therapeutics President, R&D Crystal Adam disposes of USD 734,514 common shares
  • Crystal Adam, President, R&D at Tango Therapeutics, cut her stake to 115,743 shares in transactions dated Aug. 3, 2026.
  • Exercised stock options for 27,000 shares at $5.2.
  • Sold 27,000 shares at weighted average prices of $26.79 and $27.35.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335002), on August 05, 2026, and is solely responsible for the information contained therein.